INformed choice in cancer screening
A partir d'une enquête en ligne menée auprès de 317 participants américains d'âge compris entre 50 et 69 ans, cette étude analyse les informations délivrées par les médecins sur les risques associés à un test de détection précoce du cancer (surdiagnostic, surtraitement)
A couple of years ago one of my undergraduate students was interested in how men felt about overdiagnosis in prostate cancer screening. He surveyed 30 men who worked for Dartmouth College Facilities or the local police and fire departments. Their mean age was 50 years; half had been screened with prostate-specific antigen. Ten percent would not agree to screening if it resulted in more than 1 overtreated person per 1 cancer death adverted, and 63% would not agree to screening if it resulted in 25 or more overtreated persons per 1 death adverted....
JAMA Internal Medicine , commentaire, 2012